As Philips reaches a consent decree agreement with the FDA that will temporarily suspend its sales of sleep therapy devices in the U.S., competitor ResMed, meanwhile, is ramping up its product ...

The Philips respiratory machine recall is a no-win situation for patients and doctors. But for the medical device giant’s longtime rivals and new competitors, business is looking up. “We think it will ...

Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics. His stories explore how tech is changing the ...

When investors think of ASX healthcare stocks, a handful of names stand out as global leaders. ResMed Inc. (ASX: RMD) is one of them. It is an ASX share that has quietly become a powerhouse in sleep ...